Loading...
Back to narrative

Stellantis will navigate a medium-term turnaround despite short-term challenges

IA Analysis

STLAP logo
STLAP
Janpeo
Invested
Published 19 Sep 2025
41 viewsusers have viewed this narrative update

Update shared on 30 Apr 2026

23 May
€5.90
Janpeo's Fair Value
€11.00
46.4% undervalued intrinsic discount
Loading
1Y
-30.4%
7D
-5.3%

Stellantis – Thesis Update (Pre–Investor Day)

Following Q1 2026 results, the investment case for Stellantis N.V. remains intact, but with a clearer distinction between operational recovery and earnings quality. The company has now confirmed a rebound in volumes (+6% revenues, +12% shipments), and a return to profitability, supporting the view that the business has passed its cyclical trough. However, underlying margins remain structurally weak—particularly in North America—where adjusted profitability falls below consensus when excluding temporary tariff-related accounting effects. Europe, while stabilizing in volume, continues to suffer from pricing pressure and unfavorable mix.

We maintain an intrinsic value of ~€11 per share, broadly aligned with normalized earnings power under mid-cycle conditions (4–5% margins and modest multiple re-rating). At this stage, no downward revision is warranted, as the company has reaffirmed its 2026 guidance and the recovery trajectory remains visible. That said, the valuation is now more explicitly execution-dependent, with limited margin visibility in the near term and free cash flow still negative.

Over a 36-month horizon, the thesis continues to rest on three pillars: (1) margin normalization in North America as product mix improves, (2) stabilization and gradual recovery in Europe following the current pricing reset, and (3) conversion of volume growth into positive and sustainable free cash flow, expected by 2027. Under these conditions, the current valuation continues to offer asymmetric upside relative to downside risk, albeit with a longer and more volatile path than initially anticipated.

Conclusion: The intrinsic value remains unchanged at ~€11, but the investment case has shifted from a near-term recovery story to a medium-term execution-driven turnaround, with value realization increasingly backloaded into 2027–2028.

Have other thoughts on Stellantis?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

The user Janpeo has a position in ENXTPA:STLAP. Simply Wall St has no position in any of the companies mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The author of this narrative is not affiliated with, nor authorised by Simply Wall St as a sub-authorised representative. This narrative is general in nature and explores scenarios and estimates created by the author. The narrative does not reflect the opinions of Simply Wall St, and the views expressed are the opinion of the author alone, acting on their own behalf. These scenarios are not indicative of the company's future performance and are exploratory in the ideas they cover. The fair value estimates are estimations only, and does not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that the author's analysis may not factor in the latest price-sensitive company announcements or qualitative material.